📊 BCPC Key Takeaways
Investment Thesis
Balchem demonstrates exceptional financial health with robust profitability, strong cash generation, and conservative leverage. Revenue growth of 8.8% coupled with impressive 20.5% net income growth indicates operational leverage and efficiency improvements. The company's strong free cash flow conversion (18.4% FCF margin) and fortress balance sheet position it well for sustainable value creation.
BCPC Strengths
- Outstanding profitability with 20.5% YoY net income growth significantly outpacing 8.8% revenue growth, indicating strong operational leverage
- Exceptional cash generation with $190.7M free cash flow (18.4% of revenue) and 35.2x interest coverage ratio
- Conservative capital structure with 0.12x debt-to-equity ratio and $74.6M cash position providing financial flexibility
- Healthy margins across the board: 35.7% gross margin, 20.2% operating margin, 14.9% net margin
- Strong liquidity with 2.07x current ratio and 1.33x quick ratio supporting operational stability
- Solid return metrics with 12.3% ROE and 9.2% ROA demonstrating efficient capital deployment
BCPC Risks
- Moderate diluted EPS growth of 20.9% suggests some share dilution offsetting earnings expansion
- Relatively modest revenue growth of 8.8% may indicate market maturity or competitive pressures in chemical sector
- High insider activity (24 Form 4 filings in 90 days) warrants monitoring for potential signaling issues
- Economic sensitivity as chemicals sector participant could face headwinds during recession
Key Metrics to Watch
- Operating margin trend and gross margin sustainability amid input cost pressures
- Free cash flow conversion rate and capital allocation decisions (dividends vs. buybacks vs. M&A)
- Revenue growth acceleration and market share dynamics in core segments
BCPC Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 2.07x current ratio provides a solid financial cushion.
BCPC Profitability Ratios
BCPC vs Default Sector
How BALCHEM CORP compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
BCPC Balance Sheet & Liquidity
BCPC 5-Year Financial Trend
5-Year Trend Summary: BALCHEM CORP's revenue has grown significantly by 30% over the 5-year period, indicating strong business expansion. The most recent EPS of $3.35 reflects profitable operations.
BCPC Growth Metrics (YoY)
BCPC Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $239.9M | $29.0M | $1.03 |
| Q2 2025 | $234.1M | $29.0M | $0.98 |
| Q1 2025 | $239.7M | $29.0M | $0.89 |
| Q3 2024 | $229.9M | $22.7M | $0.90 |
| Q2 2024 | $231.3M | $22.7M | $0.93 |
| Q1 2024 | $232.5M | $22.7M | $0.70 |
| Q3 2023 | $229.9M | $22.7M | $0.78 |
| Q2 2023 | $231.3M | $22.7M | $0.92 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
BCPC Capital Allocation
BCPC SEC Filings
Access official SEC EDGAR filings for BALCHEM CORP (CIK: 0000009326)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BCPC
What is the AI rating for BCPC?
BALCHEM CORP (BCPC) has an AI rating of STRONG BUY with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are BCPC's key strengths?
Outstanding profitability with 20.5% YoY net income growth significantly outpacing 8.8% revenue growth, indicating strong operational leverage. Exceptional cash generation with $190.7M free cash flow (18.4% of revenue) and 35.2x interest coverage ratio.
What are the risks of investing in BCPC?
Moderate diluted EPS growth of 20.9% suggests some share dilution offsetting earnings expansion. Relatively modest revenue growth of 8.8% may indicate market maturity or competitive pressures in chemical sector.
What is BCPC's revenue and growth?
BALCHEM CORP reported revenue of $1.0B.
Does BCPC pay dividends?
BALCHEM CORP pays dividends, with $28.3M distributed to shareholders in the trailing twelve months.
Where can I find BCPC SEC filings?
Official SEC filings for BALCHEM CORP (CIK: 0000009326) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BCPC's EPS?
BALCHEM CORP has a diluted EPS of $4.75.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.